JRJonathan M. Rubin

Jonathan M. Rubin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonathan M. Rubin has a total of 151 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thermoacoustic Ultrasound Assessment of Liver Steatosis—A Novel Approach for MASLD Diagnosis

    by Jang Hwan Cho, Christopher M. Bull, Michael Thornton, Jing Gao, Jonathan M. Rubin, Idan Steinberg

    Background/Objectives: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a global health crisis, but current diagnostics are limited. Liver biopsy is invasive, magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is expensive, and quantitative ultrasound methods are low-accuracy, especially in patients with a high body mass index (BMI). This study introduces a novel thermo-acoustic (TA) method that generates ultrasound signals based on tissue electrical conductivity, where lean tissue (high in water and electrolytes) absorbs more radio-frequency (RF) energy than fatty tissue, providing a direct molecular contrast for fat. Methods: A prospective, cross-sectional feasibility study compared a new thermo-acoustic fat fraction (TAFF) score with the reference standard MRI-PDFF in 40 subjects with suspected fatty liver disease. Bland–Altman analysis, Deming regression, and Binary classification performance were tested. To establish system stability, a dedicated Repeatability and Reproducibility (R&R) study (N = 14) evaluated inter-operator and intra-operator consistency using an Intraclass Correlation Coefficient (ICC) derived from a two-way random-effects ANOVA model. Results: TAFF estimates demonstrated a substantial correlation (r = 0.89) with MRI-PDFF and an average absolute error of 3.04% fat fraction. Classification performance was high, with an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.92 at the 12% fat fraction threshold and 0.99 at the 20% fat fraction threshold. The R&R study confirmed robust stability (intraclass correlation = 0.89) and a negligible mean inter-operator difference of 0.36%. Estimation errors showed no statistically significant correlation with BMI or other body habitus measurements. Conclusions: These findings support thermoacoustics’ potential as an accurate, non-invasive, point-of-care solution that can serve as a new imaging biomarker. By providing predictive values closely aligned with MRI-PDFF across the full MASLD spectrum, TAFF can complement currently available ultrasound methods to address the cost and access constraints of MRI for the assessment, diagnosis, and monitoring of MASLD.


  • Open Access

    Statistical modeling of blood and tissue signatures using ultrasonic color flow imaging

    by Atefeh Abdolmanafi, Jonathan Rubin, Stephen Z Pinter, J Brian Fowlkes, Oliver Kripfgans

    Conventional color flow processing is primarily optimized for qualitative visualization of flow dynamics, limiting its diagnostic use in regions where vascular structures are small relative to the ultrasound beamwidth. Leveraging the statistical properties of color flow data may provide a pathway toward quantitative discrimination between blood and tissue signals. This could enhance detection of vascular abnormalities, improve diagnostic accuracy, and support monitoring in diseases with small hemodynamic changes. Experimental data was obtained using a clinical GE LOGIQ 9 ultrasound system with a 10L linear array probe (3.75 MHz) positioned on an in-house made half-space flow phantom with the focus located at 3 cm depth. The simulation data obtained from Field II used a setup analogous to the experimental settings. Theoretical probability density function of ultrasound color flow power was derived using a gamma distribution. Shape parameters for blood and tissue were estimated using maximum likelihood estimation (MLE) in both simulation and experimental data. Color flow power was found to follow the gamma distribution in both simulation and experimental data. The estimated shape parameters aligned with theoretical predictions and distinguished between blood and tissue. Estimated shape parameters are less than or equal to 1 for tissue samples and greater than 1 for blood samples. This study presents a statistical modeling approach to enhance blood-tissue differentiation in color flow ultrasound, enabling blood characterization and perfusion quantification for improved detection and monitoring of vascular abnormalities.

  • Open Access

    Thermoacoustic ultrasound assessment of liver steatosis - a novel approach for MASLD diagnosis

    by Jang Hwan Cho, Christopher Marsh Bull, Michael Thornton, Jing Gao, Jonathan M. Rubin, Idan Steinberg

    Background/Objectives: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a global health crisis, but current diagnostics are limited. Liver biopsy is invasive, magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is expensive, and quantitative ultrasound methods are low-accuracy, especially in patients with a high body mass index (BMI). This study introduces a novel thermo-acoustic (TA) method that generates ultrasound signals based on tissue electrical conductivity, where lean tissue (high in water and electrolytes) absorbs more radio-frequency (RF) energy than fatty tissue, providing a direct molecular contrast for fat. Methods: A prospective, cross-sectional feasibility study compared a new thermo-acoustic fat fraction (TAFF) score with the reference standard MRI-PDFF in 40 subjects with suspected fatty liver disease. Bland Altman analysis, Deming regression, and Binary classification performance were tested. To establish system stability, a dedicated Repeatability and Reproducibility (R&R) study (N = 14) evaluated inter-operator and intra-operator consistency using an Intraclass Correlation Coefficient (ICC) derived from a two-way random-effects ANOVA model. Results: TAFF estimates demonstrated a substantial correlation (r =0.89) with MRI-PDFF and an average absolute error of 3.04% fat fraction. Classification performance was high, with an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.92 at the 12% fat fraction threshold and 0.99 at the 20% fat fraction threshold. The R&R study confirmed robust stability (intraclass correlation = 0.89) and a negligible mean inter-operator difference of 0.36%. Estimation errors showed no statistically significant correlation with BMI or other body habitus measurements. Conclusions: These findings support thermoacoustics’ potential as an accurate, non-invasive, point-of-care solution that can serve as a new imaging biomarker. By providing predictive values closely aligned with MRI-PDFF across the full MASLD spectrum, TAFF can complement currently available ultrasound methods to address the cost and access constraints of MRI for the assessment, diagnosis, and monitoring of MASLD.

  • Ultrasound Strain Zero‐Crossing for Assessing Adult Hypertonic Muscles

    by Jing Gao, Jonathan M. Rubin

    Objectives: To assess the feasibility of ultrasound strain zero‐crossing (ZC) to assess adult hypertonic muscles. Methods: After receiving Institutional Review Board (IRB) approval and informed consent, we prospectively performed free‐hand compression ultrasound strain imaging (USI) on normal and hypertonic upper trapezius muscles (UTM) and subcutaneous tissues using a linear array transducer (10L4, bandwidth 4–10 MHz). Ultrasound data containing tissue deformation and relaxation produced by axial compression and decompression were processed using 2D speckle tracking software. Using the ZC point on the reference strain curve as the reference, we determined a negative ZC if the muscle strain curve returned to zero strain after or at the same time as that of the reference curve. We determined a positive ZC when the muscle strain curve returned to zero strain ahead of the reference curve. Modified Ashworth Scale (MAS) was used to assess muscle tonicity performed by clinicians. The difference in ZC between normal and hypertonic muscles and the diagnostic performance of ZC in determining ≥mild hypertonic muscles were analyzed using a paired t ‐test and the receiver operating characteristic curve (ROC), respectively. Results: From October 2023 to August 2024, we performed USI on 28 subjects with normal muscles and 56 with hypertonic muscles (38 men and 46 women, mean age: 52 years). The difference in ZC between normal and hypertonic muscles was statistically significant ( P < .001). The area under the ROC of ZC for determining ≥mild hypertonic muscles was 0.92. Conclusions: The study results suggest that ultrasound strain ZC is feasible for determining ≥mild hypertonic muscles with good diagnostic performance.


  • The Effect of Backscatter Anisotropy in Assessing Hepatic Steatosis Using Ultrasound Hepatorenal Index

    by Jing Gao, Ben Wilde, Oliver D. Kripfgans, Johnson Chen, Jonathan M. Rubin

    Objectives: To discuss challenges in assessing hepatic steatosis using ultrasound hepatorenal index (HRI).Methods: We retrospectively analyzed HRI and liver magnetic resonance imaging‐based proton density fat fraction (MRI‐PDFF) in 134 adult participants (53 men and 81 women, mean age 55 years). The diagnostic performance of HRI for determining hepatic steatosis was tested by the area under the receiver operating characteristic curve (AUROC) using liver MRI‐PDFF as the reference. Regression plots were employed to compare the sampling sites in liver and kidney that were used to calculate HRIs.Results: In 11 of 134 cases (8.2%), we failed to acquire HRI measurements. In the remaining 123 cases, AUROC for HRI (cutoff: 1.69 ± 0.13 [mean ± standard deviation]) for defining the HRI threshold for diagnosing hepatic steatosis was 0.83. In 60 of 123 cases (49%) with HRI measurement IQR/median >0.3, slopes of the regression lines in the liver showed backscatter intensity changes consistent with signal attenuation. However, in the kidney, the backscatter intensity was inverted yielding position‐dependent HRI cutoff values, mid‐pole = 2.24 ± 0.20 and upper pole = 1.08 ± 0.16.Conclusions: HRI is used to estimate liver steatosis based on backscattered ultrasound. In order to compensate for effects such as body habitus and transducer frequency, the liver backscatter is divided by backscatter from a corresponding region at the same depth in the right renal cortex. Theoretically, this compensation should make HRI sampling position independent. Yet, due to renal cortical backscatter anisotropy, this compensation method does not work in general, potentially producing inaccurate liver fat estimates.


  • Open Access

    Comment on Barbieri et al. Umbilical Vein Blood Flow in Uncomplicated Pregnancies: Systematic Review of Available Reference Charts and Comparison with a New Cohort. J. Clin. Med. 2023, 12, 3132

    by Jonathan M. Rubin, Oliver D. Kripfgans

    We would like to comment on the systemic review article published in the Journal of Clinical Medicine by Barbieri et al


  • Placental assessment using spectral analysis of the envelope of umbilical venous waveforms in sheep

    by Jonathan M. Rubin, Stephen Z. Pinter, Katherine M. Halloran, Brooke D. Pallas, J. Brian Fowlkes, Arpita K. Vyas, Vasantha Padmanabhan, Oliver D. Kripfgans

  • Open Access

    Figure S3 from TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell–Mediated Regression of Pancreatic Cancer

    by Daniel R. Principe, Alex Park, Matthew J. Dorman, Sandeep Kumar, Navin Viswakarma, Jonathan Rubin, Carolina Torres, Ronald McKinney, Hidayatullah G. Munshi, Paul J. Grippo, et al.

  • Open Access

    Figure S5 from TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell–Mediated Regression of Pancreatic Cancer

    by Daniel R. Principe, Alex Park, Matthew J. Dorman, Sandeep Kumar, Navin Viswakarma, Jonathan Rubin, Carolina Torres, Ronald McKinney, Hidayatullah G. Munshi, Paul J. Grippo, et al.

    Figure S5 shows additional H&E stained sections from Galunisertib and/or anti-PD-1 treated mice.